Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
PRNewswire - December 13, 2001
The meeting is scheduled to follow the "7th International Antibacterial Drug Discovery & Development Summit," and will be held concurrently with the "6th International Antifungal Drug Discovery & Development Summit."
The Antiviral & Vaccine Summit, focused on industrial applications in the pharmaceutical industry, features as presenters, many of the leading firms, large and small, in providing comprehensive scientific presentations on the latest advances in the quest for new and better antiviral drugs. This is also the first ever meeting to combine vaccine R & D efforts, along with antiviral research.
The meeting is divided into five discrete sections: 1) HIV, 2) HBV/HCV, 3) Vaccine R & D, 4) Other Antiviral Efforts (Influenza, HPV, RSV), & 5) Emerging Antiviral Technologies. Highlights include presentations by Visible Genetics on The First FDA Resistance Technology Approval, and Georgetown University's presentation on Antiviral Efficacy of Topical DNA Vaccines.
Presenters include: Abbott Labs, Apath Inc, Boehringer-Ingelheim Canada, Cellexsys Targeted Genetics, Chiron Corporation, Dupont Pharmaceuticals, Eli Lilly & Company, Georgetown University, Hoffman-La Roche, Koronis Pharmaceuticals, Maxygen Inc, Merck Research Labs, Novirio Pharmaceuticals, Research Institute for Genetic & Human Therapy, Schering Plough Research Institute, Tibotec Inc, Triangle Pharmaceuticals, Visible Genetics, Wyeth-Lederle Vaccines, & Zycos Inc.
To receive the full agenda in PDF format and/or register for the conference, please contact Jackie Ni at jni@srinstitute.com or at 212.967.0095, x270. Include your fax number, affiliation and email address. You may also kindly request PDF's of the 7th Antibacterial Summit & the 6th Antifungal Summit as well.
To participate in the poster session or exposition, please contact Mark Alexay at malexay@srinstitute.com or 212-967-0095 x251 to request details; THE FIRST TEN REGISTERED EXHIBITORS AND SPONSORS WILL EACH BE PERMITTED A ONE-MINUTE INTRODUCTION OF THEIR COMPANIES TO THE AUDIENCE EITHER DURING THE AM OR PM BREAK ON MARCH 13.
011213
PR011230
Copyright © 2001 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.PRNewswire.com.
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .